Study guide

19.1 Withdrawal, Elopement, De-escalation & Risk Reduction

Pediatric Nursing Certification PED-BC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, Blueprint & Clinical Decision-Making

1.1 ANCC PED-BC Exam Facts, Scoring & Test Blueprint 1.2 The Pediatric Nursing Process & Clinical Judgment Model 1.3 Prioritization, Clinical Case Analysis & Practice Strategies

2 Chapter 2: Pediatric Growth, Development & Milestones

2.1 Infancy and Toddlerhood: Physical Growth & Motor Milestones 2.2 Preschool, School-Age & Adolescent Milestones 2.3 Developmental Theories: Erikson, Piaget, Kohlberg & Freud

3 Chapter 3: Pediatric Physical Assessment, Vital Signs & Diagnostic Screening

3.1 Pediatric Physical Examination & Age-Specific Vital Sign Norms 3.2 Pediatric Pain Assessment Scales & Developmental Screening 3.3 Pediatric Laboratory Values & Diagnostic Specimen Collection

4 Chapter 4: Pediatric Fluid, Electrolyte & Nutritional Management

4.1 Dehydration Severity, Oral Rehydration Therapy & IV Deficit Replacement 4.2 Pediatric Electrolyte Disturbances: Sodium, Potassium & Calcium Imbalances 4.3 Infant Nutrition, Formula Preparation, Failure to Thrive & Deficiencies

5 Chapter 5: Pediatric Respiratory Emergencies & Chronic Pulmonary Conditions

5.1 Upper Airway Obstruction: Croup, Epiglottitis & Foreign Body Aspiration 5.2 Lower Airway Infections: Bronchiolitis (RSV) & Pediatric Pneumonia 5.3 Chronic Pulmonary Disorders: Pediatric Asthma & Cystic Fibrosis Management

6 Chapter 6: Pediatric Congenital & Acquired Cardiovascular Disorders

6.1 Acyanotic Congenital Heart Defects: Left-to-Right Shunts & Obstructive Lesions 6.2 Cyanotic Defects & Complex Anomalies: Tetralogy of Fallot, TGA & Hypercyanotic Spells 6.3 Acquired Pediatric Heart Disease: Kawasaki Disease, Rheumatic Fever & Heart Failure

7 Chapter 7: Pediatric Neurological & Neuromuscular Disorders

7.1 Pediatric Seizure Disorders: Febrile Seizures, Epilepsy & Status Epilepticus 7.2 Central Nervous System Infections & Increased Intracranial Pressure 7.3 Structural Anomalies & Neuromuscular Disorders: Hydrocephalus, VP Shunts, Spina Bifida & Cerebral Palsy

8 Chapter 8: Pediatric Gastrointestinal & Hepatic Conditions

8.1 Acute Surgical Conditions: Pyloric Stenosis, Intussusception & Appendicitis 8.2 Congenital & Structural GI Anomalies: Cleft Lip/Palate, TEF & Hirschsprung Disease 8.3 Chronic GI & Malabsorption: Pediatric GERD, Celiac Disease & Inflammatory Bowel Disease

9 Chapter 9: Pediatric Renal & Genitourinary Conditions

9.1 Pediatric Urinary Tract Infections, Vesicoureteral Reflux & Enuresis 9.2 Glomerular Disorders: Minimal Change Nephrotic Syndrome & Acute Post-Streptococcal Glomerulonephritis 9.3 Hemolytic Uremic Syndrome, Acute Kidney Injury & Structural Genital Anomalies

10 Chapter 10: Pediatric Hematologic & Oncologic Conditions

10.1 Pediatric Anemias & Sickle Cell Disease Crises 10.2 Pediatric Bleeding Disorders: Hemophilia A/B & Immune Thrombocytopenia 10.3 Pediatric Leukemias, Solid Tumors & Oncologic Emergencies

11 Chapter 11: Pediatric Endocrine & Inborn Metabolic Disorders

11.1 Pediatric Type 1 Diabetes Mellitus & Diabetic Ketoacidosis Protocols 11.2 Pediatric Thyroid, Adrenal & Growth Hormone Disorders 11.3 Inborn Errors of Metabolism & Pubertal Disorders: PKU, Galactosemia & Precocious Puberty

12 Chapter 12: Pediatric Musculoskeletal, Integumentary & Infectious Disorders

12.1 Pediatric Orthopedics: Developmental Dysplasia of the Hip, Clubfoot, Scoliosis & Fractures 12.2 Pediatric Burns, Atopic Dermatitis & Dermatologic Conditions 12.3 Viral Exanthems, Communicable Diseases & Pediatric Sepsis Management

13 Chapter 13: Pediatric Pharmacology, Safe Dosage & Immunizations

13.1 Pediatric Pharmacokinetics, Weight-Based Calculations & Safe Dosing Limits 13.2 High-Alert Pediatric Medications, IV Infusion Safety & Vascular Access 13.3 CDC Childhood Immunization Schedules, Vaccine Safety & Catch-Up Guidelines

14 Chapter 14: Family-Centered Care, Psychosocial Health & Injury Prevention

14.1 Family-Centered Care Principles, Hospitalization Stress & Separation Anxiety 14.2 Developmentally Appropriate Procedural Preparation & Non-Pharmacological Comfort 14.3 Anticipatory Guidance, Car Seat Safety, Drowning & Poisoning Prevention

15 Chapter 15: Professional Role, Ethics, Legal Standards & Advocacy

15.1 Informed Consent, Minor Assent & Adolescent Confidentiality Rights 15.2 Mandatory Reporting: Identifying Child Abuse, Neglect & Human Trafficking 15.3 Evidence-Based Practice, Pediatric Quality Metrics & Interprofessional Collaboration

16 Chapter 16: Medication Reconciliation, Complementary Care & Interactions

16.1 Medication, Allergy & Treatment Reconciliation 16.2 Complementary Products & Treatment Interactions

17 Chapter 17: Individualized Assessment, Diversity & Psychosocial Safety

17.1 Culture, Resources, Religion & Individualized Care 17.2 Psychosocial Screening & Immediate Mental Health Safety

18 Chapter 18: Individualized Planning, Coordination & Family Teaching

18.1 Measurable Outcomes, Coordination & Delegation 18.2 Teach-Back, Return Demonstration & Learning Evaluation

19 Chapter 19: Patient Safety, Chronic Care & Outcome Evaluation

19.1 Withdrawal, Elopement, De-escalation & Risk Reduction 19.2 Chronic Care, Healthy Weight & Response Evaluation

19.1 Withdrawal, Elopement, De-escalation & Risk Reduction

Key Takeaways Explain This Topic AI

A risk score supports assessment and does not replace attention to clinical trends or caregiver concerns.

Withdrawal after prolonged sedative or opioid exposure requires a prescribed monitoring and taper plan.

De-escalation addresses pain, fear, sensory needs, and communication before avoidable coercion.

Restraint requires applicable authorization, monitoring, alternatives, and repeated evaluation; it is never a staffing substitute.

Last updated: October 2026

Assess several risks without losing the child

A hospitalized child can face pressure injury, falls, medication effects, withdrawal, elopement, infection, and behavioral distress at the same time. Risk reduction requires an individualized plan rather than the same precaution for every child. Use the validated tool adopted by the institution for the relevant age and setting, then integrate examination, baseline function, devices, medications, caregiver information, and clinical trends.

A low score cannot make a visibly deteriorating child safe. Equally, a high score should lead to targeted interventions instead of an automatic label that restricts development unnecessarily. Reassess when medication, mobility, cognition, equipment, or family circumstances change. Explain precautions in understandable language so the child and family can participate.

Withdrawal and deterioration are not interchangeable

After prolonged opioid or sedative exposure, a child may need a planned taper and withdrawal monitoring. Symptoms such as agitation, disturbed sleep, sweating, gastrointestinal symptoms, or altered vital signs can have several causes. Review recent drugs, duration, last doses, taper instructions, and baseline behavior. Use the institution's appropriate withdrawal tool and escalation pathway; do not diagnose withdrawal from irritability alone.

Assess pain, oxygenation, infection, delirium, hypoglycemia, and other clinical explanations when indicated. A missed sedative dose does not rule out sepsis, and a reassuring withdrawal score does not rule out respiratory compromise. Administer rescue or taper medication only under the prescribed plan. Document the score, the clinical findings, treatment, and response so the next clinician can interpret the trend.

Prevent falls and pressure injury

Select age-appropriate bed or crib protection, maintain safe equipment placement, supervise mobility according to ability, and account for sedating drugs or unfamiliar surroundings. A child newly learning to use crutches has a different risk from an infant with several attached devices. Explain how the caregiver should request help rather than assuming continuous parental presence eliminates fall risk.

Inspect skin and device contact points, including under oxygen interfaces, splints, casts, and tubing when clinically appropriate. Adjust positioning and protection within the treatment plan. A pressure-risk tool supports prevention but does not replace looking beneath a device or responding to a new area of erythema. Document changes and coordinate with the team when the prescribed device itself creates a problem.

Elopement prevention is individualized

Ask about wandering, impulsivity, developmental or cognitive differences, prior elopement, distress triggers, and caregiver strategies. Establish who supervises the child, how to request help, and how to respond if the child is missing. Use identification and environmental precautions required by policy. A security process should support clinical care without treating a distressed or developmentally different child as deliberately disobedient.

For an adolescent requesting to leave, assess the reason and immediate safety, verify the relevant legal status and consent framework, and involve the responsible clinician. Do not assume that a minor can never leave or that every request permits physical detention. Emergency safety and legal authority must be addressed through the institution's established process.

De-escalate before avoidable restraint

Look for pain, fear, overstimulation, communication barriers, hunger, fatigue, and a previous traumatic experience. Reduce unnecessary people and noise, allow physical space, speak calmly, explain what will happen, and offer realistic choices. Invite a familiar caregiver when helpful and safe. Ask about the child's preferred communication and coping methods. Avoid threats, humiliation, surprise touching, or arguing during escalation.

Escalation cue Possible contributor Individualized response

Pulling at a mask Fear, discomfort, fit, breathing difficulty Assess the child and device before labeling behavior

Hiding before a procedure Anticipatory anxiety Explain, rehearse, and plan comfort positioning

Repeatedly approaching an exit Separation, sensory distress, unmet need Clarify the need and implement the safety plan

  • Sudden agitation after a clinical change Pain or physiological deterioration Assess medical causes promptly
  • Restraint and infection precautions require active monitoring

Use the least restrictive effective approach and applicable orders, reassessment, documentation, and monitoring. Requirements depend on the indication, age, jurisdiction, and policy; do not substitute a single universal time interval for the actual rule. Evaluate airway, breathing, circulation, skin, comfort, hydration, elimination, and readiness for release as appropriate. Restraint cannot replace adequate supervision or punish a child for distress.

Infection prevention also needs specific application: hand hygiene, indicated transmission precautions, aseptic access, device necessity review, and age-appropriate family teaching. Chlorhexidine products require attention to age, formulation, indication, skin condition, and institutional guidance; a bundle for an older child cannot automatically be applied to a premature infant. Prevent pooling, unintended exposure, and use on prohibited sites.

Evaluate risk reduction through actual outcomes and balancing effects. A plan that prevents a child from pulling a line but causes severe distress or skin injury needs revision. Communicate the successful calming approach, device concerns, observation level, and pending safety actions during handoff. The next team should inherit a usable plan, not just a list of risk labels.

ANCC current outline includes withdrawal assessment, elopement, restraints, de-escalation, and infection prevention. For suicide-specific precautions, use the NIMH clinical pathway .